Home Cart Sign in  
Chemical Structure| 1164116-14-6 Chemical Structure| 1164116-14-6

Structure of 1164116-14-6

Chemical Structure| 1164116-14-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1164116-14-6 ]

CAS No. :1164116-14-6
Formula : C8H12ClN3
M.W : 185.65
SMILES Code : NC1=NC(CC(C)C)=NC(Cl)=C1

Safety of [ 1164116-14-6 ]

Application In Synthesis of [ 1164116-14-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1164116-14-6 ]

[ 1164116-14-6 ] Synthesis Path-Downstream   1~1

  • 1
  • C8H12ClN3 [ No CAS ]
  • [ 1164116-14-6 ]
  • [ 392338-15-7 ]
  • [ 1164116-43-1 ]
YieldReaction ConditionsOperation in experiment
32% With N-ethyl-N,N-diisopropylamine; In butan-1-ol; at 100℃; EXAMPLE 1; 2-lsobutyl-6-((3R)-3-(methylamino)pyrrolidin-1-yl)pyrimidin-4-amine; The compound obtained in reference example 1 (144 mg, 0.72 mmol) was added to a solution of reference example 3 (89 mg as an approx 50% mixture of the two regioisomers, 0.48 mmol equivalents to 0.24 mmol of the intended regioisomer) and DIEA (0.25 ml_, 1.44 mmol) in n-BuOH (6 ml_), and the resulting mixture was heated overnight in a sealed tube at 100 C. Additional reference example 1 (96 mg, 0.48 mmol) and DIEA (0.25 ml_) were added and it was heated at 100 0C for one more day. It was allowed to cool and the solvent was evaporated to dryness. The crude product obtained was purified by preparative HPLC-MS (column X- Terra PREP MS C18 5 mum (100 mm x 19 mm), rate: 20 mL/min, eluent: A = AcN, B = NH4HCO3 75 mM, gradient: 0 min A at 25%; 1 min A at 25%; 11 min A at 90%; 12 min A at 90%) and the fractions containing the product were evaporated to dryness, providing 26.9 mg of the Boc-protected intermediate (yield: 32%). ,HCI (4 M solution in 1 ,4-dioxane, 1.5 mL) and MeOH (1 mL) were added to this intermediate, and the mixture was stirred at room temperature for 2 hours. The solvent was evaporated to dryness. The residue was dissolved in water, 1 N NaOH solution was added until basic pH and it was extracted three times with chloroform. The combined organic phases were dried over anhydrous Na2SO4 and it was concentrated to dryness. The crude product obtained was purified by preparative HPLC-MS (column X-Terra PREP MS C18 5 mum (100 mm x 19 mm), <n="83"/>rate: 20 ml_/min, eluent: A = AcN, B = NH4HCO3 75 mM, gradient: 0 min A at 10%; 1 min A at 10%; 8 min A at 90%) and the fractions containing the product were evaporated to dryness, providing 5.2 mg of the title compound (yield: 27%). LC-MS (Method 2): tR = 1.20 min; m/z 250 (MH+).
 

Historical Records